1998 Global Conference Proceeding
March 02 - 04, 1998
| Conference: | 1998 Global Conference |
|---|---|
| Title: | Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. |
| Authors: | Morin, Denis; Ala, Youssef; Sabatier, Nancy; Vargas-Poussou, Rosa; Alonso, Gerard; Hibert, Marcel; Turaner, M.S.; Barberis, Claude; Bichet, Daniel G.; Jard, Serge |
| Institutions: | INSERM U469, INSERM 469 & 336, INSERM 469 and 336, Hopital Necker-Enfants Malades Tour Lavoisier, Marion Merrell Dow Research Institute, Hopital du Sacre-Coeur de Montreal, Unite INSERM 469, Unit? INSERM |
X-linked nephrogenic diabetes insipidus (NDI) occurs when mutations in the arginine-vasopressin receptor (AVPR2) cause the receptor to be unresponsive to the action of the antidiuretic hormone, vasopressin. Morin, et. al., studying the loss of function of mutant receptors found in different patients, created 12 mutant receptors and studied their function in laboratory conditions. Eleven of the mutant receptors were completely dysfunctional, but one, P322S, was able to function to a degree. The patient with this mutation did not have any developmental delay, his NDI expressed itself late, and he showed an increased ability to concentrate urine after injection of synthetic arginine-vasopressin.
In its non-mutated form, V2 receptor P322 plays an important role in receiving the antidiuretic message. In one of its mutated forms - P322H - the receptor is completely dysfunctional. As Morin, et. al's., work shows, however, another one of its mutated forms - P322S - exhibits only mild dysfunction. This illustrates how even slight changes (mutations) in genetic sequencing (in this case a single amino acid switch) can determine both impairment and degrees of impairment in receptor function.
